|
CLYM Climb Bio Inc 1768446 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-13,498,000.00 |
| Balance Sheet |
|
Current Assets
|
$186,636,000.00 |
|
Assets
|
$246,294,000.00 |
|
Current Liabilities
|
$5,934,000.00 |
|
Liabilities
|
$6,747,000.00 |
|
Equity
|
$239,547,000.00 |
|
Shares Out
|
57436255.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,925,000.00 |
|
Investing Cash Flow
|
$-70,218,000.00 |
| Market Analysis |
Market Cap
|
$977,565,060.10 |
|
Price
|
$14.05 |
|
BVPS
|
4.17 |
|
PB
|
4.08 |
|
EPS
|
-0.18 |
|
FCF
|
$-29,570,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:28 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLYM documents filed with the SEC.
CLYM Filings
Clear
